Generic Semaglutide: Lower-Cost Semaglutide is Here!
BUY NOW
We Ship To The U.S. Only
How Long Does Eliquis Stay in Your System? Understanding the Half-Life and Elimination Timeline
- Posted On:
- 19 Jun, 2026
- 13 min read
-
Eliquis (Apixaban): Effective blood thinner for reducing the risk of clots in certain conditions.Starting From $18.33
10% Off On Your First Order
Click on the Copy Code button to copy your code.
No Expiry
Exclusive On Duty Free Meds Only
Eliquis (apixaban) is a type of anticoagulant that is used to treat a couple of different medical issues. It is used for reducing the risk of stroke and blood clots. It is prescribed to manage blood clot problems such as deep vein thrombosis (DVT). It is also used to help treat issues like pulmonary embolism (PE). It is commonly prescribed after knee or hip replacements or for patients with nonvalvular AFib. How long this medication stays in the body is a question asked by many patients and caregivers—especially before procedures or switching medications.
- Eliquis (Apixaban): Effective blood thinner for reducing the risk of clots in certain conditions.Starting From $18.33
10% Off On Your First Order
Click on the Copy Code button to copy your code.
No Expiry
Exclusive On Duty Free Meds Only
- Eliquis has a half-life of about 12 hours (but it can range from 8 to 15 hours depending on individual health factors)
- Most of the drug is eliminated within 48-72 hours after the last dose
- Doctors often recommend stopping Eliquis 24-72 hours before a procedure depending on bleeding risk
- Severe bleeding or urgent surgery may require reversal agents like Andexxa or activated charcoal
- Patients with significant renal impairment may retain therapeutic levels for days beyond the usual elimination window
- Eliquis has a half-life of about 12 hours (but it can range from 8 to 15 hours depending on individual health factors)
- Most of the drug is eliminated within 48-72 hours after the last dose
- Doctors often recommend stopping Eliquis 24-72 hours before a procedure depending on bleeding risk
- Severe bleeding or urgent surgery may require reversal agents like Andexxa or activated charcoal
- Patients with significant renal impairment may retain therapeutic levels for days beyond the usual elimination window
What Is the Half-Life of Eliquis?
The half-life of a drug refers to the time it takes for half of the medication to be eliminated from the bloodstream. Eliquis has an approximate half-life of 12 hours in healthy individuals. However, this half-life is not a fixed number that applies to all patients. The exact half-life of the medication in the patient’s bloodstream depends on their age and health—such as kidney function and any health conditions they have. It can range between eight and 15 hours.
How Long Does Eliquis Last in the Body?
Eliquis still stays in the body for a little while after the 12-hour half-life. It takes two to three days—or 48 to 72 hours—before the medication is fully cleared from the body. Five half-lives of this medication would be around 60 hours. About 97% of the drug should be eliminated from the bloodstream by this time. There still may be some residual trace amounts that stay in the system a little longer. However, they are not usually considered to be clinically active.
Factors That Affect How Long Eliquis Stays in the Body
The length of time it takes for Eliquis to leave the body depends on many different factors. These include:
- Kidney Function
About 25% to 27% of Eliquis is excreted by the kidneys. Reduced kidney function can slow elimination. This means the medication may stay in the system of patients with kidney issues longer. Studies show that those with severe kidney impairment may see an increased exposure of ~38–44% and the half-life of the medication may increase slightly longer—to 15.1 to 17.6 hours on average. Studies also showed that patients with end-stage renal disease who are using hemodialysis may see a half-life increase of around 36% compared to healthy subjects (after using a single 5 mg dose). - Age
Older adults may have a slightly prolonged elimination time. This is because the function of cells and organs—and how they communicate—may start to decline. Older adults also have decreased liver sizes and blood flow. They also may start to lack the cytochrome P450 enzyme—which affects the metabolism of medications. This also contributes to longer medication half-lives. - Liver Function
Eliquis is metabolized mainly via CYP3A4 and other cytochrome P450 enzymes. Mild to moderate liver impairment does not greatly alter apixaban pharmacokinetics. However, moderate to severe impairment may increase its half-life. This medication is not recommended to be taken by patients with severe liver impairment. This also includes liver disease relating to coagulopathy or clinically relevant bleeding risk. Those with mild or moderate impairment should only use this medication with caution. However, dosing adjustments may not be made as a result in all cases. - Body weight
Body weight can influence drug distribution volume and clearance. However, studies show that usually body weight alone is not enough to increase exposure to Eliquis. The increased exposure usually also has to do with other factors that overweight patients may have. One study—looking at 18 patients with normal weight, 39 obese patients, and 14 healthy controls—showed that there were two common trends for patients weighing more than 120 kg. These patients experienced a slower rise in anti-factor Xa levels after taking apixaban. They also experienced significantly less overall drug exposure compared to lighter patients. Metabolic issues—which can be weight-related—may also influence how the drug is processed. - Other Medications
Many drugs interact with Eliquis by affecting its metabolism. This is especially the case for CYP3A4 inhibitors or inducers. Strong CYP3A4 and P-glycoprotein inhibitors—such as certain antifungals and HIV protease inhibitors—can increase Eliquis levels. Antifungal medications and anti-seizure medications may also affect how long Eliquis stays in the body. Some anticonvulsants can do the opposite and induce metabolism. This limits the amount of time the drug stays in the body.
Why The Half Life Of Eliquis Matters: Surgery, Bleeding Risk, and Reversal
Those who are undergoing surgery may be advised by a doctor to stop taking Eliquis anywhere between 24 hours and 72 hours before the procedure. The exact amount of time will depend on the procedure being done. Low-risk procedures—where there is little concern of bleeding becoming out of control—usually only require 24 hours without taking the medication before the procedure can be done. This might include procedures such as those having to do with:
- Eyes
- Skin
- Teeth
- Gastrointestinal procedures
- Minor cardiac procedures
Patients will usually be told to stop taking the medication at least 48 hours before elective surgeries or those with a higher risk of bleeding. High-risk surgeries may include those such as major:
- Orthopedic surgeries
- Cancer or reconstructive surgeries
- Thoracic surgeries
- Cardiac surgeries
- Vascular surgeries
- Intracranial or neuraxial surgeries
Procedures using neuraxial anesthesia will require the medication to be stopped 72 hours ahead of time. The medication can then be resumed within a few days after the procedure has been completed and all bleeding has stopped.
Emergency Situations and Elquis Reversal
Emergency situations—such as too much bleeding occurring—often require the use of a reversal agent. This usually includes the Andexxa (andexanet alfa). This medication works by reversing the anticoagulant effects of Eliquis and other factor Xa inhibitors. Its effects can last a couple of hours after the infusion is stopped.
The dose of Andexxa given when Eliquis needs to be reversed depends on how much Eliquis the patient has taken and how long it has been since the last dose. A low-dose regimen of Andexxa is used for patients who took 5 mg or less of Eliquis. This dose involves giving a 400 mg IV bolus at a rate of 30 mg per minute. This is followed by a two-hour continuous infusion at 4 mg per minute. A high-dose regimen is required if the patient took more than 5 mg of Eliquis or if the last dose is unknown. This consists of an 800 mg IV bolus at the same rate of 30 mg per minute. This is then followed by a two-hour infusion at 8 mg per minute. In both cases, if more than eight hours have passed since the last Eliquis dose, the low-dose regimen is recommended regardless of the amount taken.
Charcoal can also be used to help in an emergency situation if the medications were taken within two to six hours prior. However, this type of reversal is usually only used when Eliquis has been taken very recently before the procedure. Patients using either of these reversal products should be closely monitored after. They should also be careful about the timing of when they take the medication to make sure blood clotting does not stop too soon or too late.
Comparing Eliquis Half-Life to Other Anticoagulant Medications
| Anticoagulant | Half-Life (Approx.) | How Long Until It Fully Leaves the System | Number of Half Lives Until It Leaves the System | Dosing Frequency | Notes |
|---|---|---|---|---|---|
| Eliquis (Apixaban) | 12 hours | 60 hours | 5 | Twice daily | Rapid onset and offset; no routine blood monitoring required |
| Xarelto (Rivaroxaban) | 5-9 hours (healthy adults), up to 13 hours in elderly | ~35 hours | 5 | Once daily (for most uses) | Slightly shorter half-life but longer dosing interval |
| Pradaxa (Dabigatran) | 12-17 hours | 24-48 hours | 2-4 | Twice daily | Requires renal dose adjustment; higher bleeding risk in some studies |
| Warfarin (Coumadin) | 20-60 hours (very long and variable) | ~72-96 hours (~3-4 days) | 3-5 | Once daily | Requires frequent INR monitoring and dietary restrictions |
| Lovenox (Enoxaparin) | 4-7 hours | Up to 35 hours | 4–7 | Once or twice daily | Injectable low molecular weight heparin; often used short-term |
| Heparin (unfractionated) | 1-2 hours | 5-7.5 hours | ~4-5 | Continuous IV or frequent injections | Used in hospital settings; short half-life requires tight dosing control |
Eliquis has a moderate half-life of about 12 hours. This means it is usually taken twice a day. This schedule helps maintain steady blood-thinning effects throughout the day without the need for constant dosing—unlike shorter half-life medications such as heparin, which often require continuous IV infusion or frequent injections.
When compared to Xarelto—which generally has a slightly shorter half-life and is often taken once daily—Eliquis requires more frequent dosing. However, this twice-daily schedule helps keep blood levels more stable. This may provide a therapeutic advantage for select patients.
Pradaxa—another direct oral anticoagulant like Eliquis—has a slightly longer half-life but comes with its own considerations. This includes kidney function adjustments and a different bleeding risk profile. Traditional warfarin has a much longer and more unpredictable half-life. It is taken daily. However, it requires frequent blood tests (INR monitoring) and dietary restrictions to keep its effects within a safe range.
Lovenox—an injectable low molecular weight heparin—has a relatively short half-life and is given once or twice daily. It is often used in the short term or to “bridge” patients onto another anticoagulant.
Drug Interactions and Clearance
There are many different drug interactions with Eliquis. These medications can cause issues such as increased blood clot risk and increased risk of patients having a serious bleeding event.
This is common when the medications are mixed with other blood thinners or NSAIDs. Antiviral and antifungal medications are also known to cause elevated Eliquis levels in the body.
Specific medications with known Eliquis interactions include:
- Cardizem (diltiazem)
- Dilantin (phenytoin)
- Kaletra (lopinavir/ritonavir)
- Ketoconazole (antifungal medication)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Norvir (ritonavir)
- Paxlovid (nirmatrelvir/ritonavir)
- Reyataz (atazanavir)
- Rifampin (an antibiotic)
- Selective serotonin reuptake inhibitors (SSRIs)
- Sporanox (itraconazole)
- Tegretol (carbamazepine)
- Other blood thinners
Some of these medications—like ketoconazole and ritonavir—can increase the concentration of the drug. This makes its effects last longer. Other medications—like rifampin and carbamazepine—can cause a decrease in Eliquis levels. This may reduce the efficiency of the medication. Patients should discuss any medication changes while taking Eliquis with their healthcare provider before making the switch. They may need to make adjustments to the treatment plan to continue safe use.
Special Populations: Renal or Hepatic Impairment
Eliquis (apixaban) can accumulate and take significantly longer to clear from the body in patients with kidney disease. For example, a reported case described a 77-year-old woman with renal impairment (CrCl 15–20 mL/min) whose apixaban level remained at 244 ng/mL—a fully therapeutic concentration—even after the medication had been held for seven days prior to surgery. In some patients—especially those with advanced kidney disease—drug levels may remain high well beyond the standard three- to four-day perioperative hold time.
Periodic checks of renal function are recommended. In high-risk scenarios—such as urgent surgery or suspected delayed clearance—specific testing may be warranted. Apixaban clearance is also reduced in dialysis patients. However, it is typically not to the same extent as in severe non-dialysis-dependent impairment.
How to Safely Stop Eliquis
Eliquis should not be stopped without direction from a medical professional. Patients who stop the medication suddenly without medical supervision may increase their risk of developing a blood clot or stroke. Speaking with healthcare providers will allow them to help organize a plan for safe bridging in the event that the medication is being stopped temporarily before a surgical procedure. Permanent stopping of the medication may require a doctor to switch the patient to an alternative anticoagulant entirely.
The Bottom Line
The half-life of Eliquis is 12 hours. However, it may take about two to three days before the medication fully leaves the patient’s system. Clearance of the medication also depends on factors such as age and kidney or liver function. It can also be affected by other medications the patient is taking. Patients should always listen to their doctor’s instructions when starting or stopping Eliquis. They also should follow the doctor’s orders on the timing of their doses.
Purchase more affordable Eliquis and other prescription medications today from Canada at Duty Free Meds.
FAQs
How long after stopping Eliquis is it safe to have surgery?
The timing depends on the type of surgery and your bleeding risk. Low-risk procedures may only require a 24-hour pause. Higher-risk or neuraxial anesthesia procedures often require 48-72 hours.
How long is Eliquis active in the bloodstream?
Most of the medication is cleared from the bloodstream within two to three days in healthy adults. However, this may take longer in people with kidney or liver problems.
Does Eliquis show up on a drug test?
Eliquis is not part of standard workplace or legal drug panels. Detecting it requires specialized laboratory testing that specifically measures apixaban levels.
How do I know if Eliquis is out of my system?
There is no at-home test to confirm this. In certain cases—such as before urgent surgery—the patient’s doctor may order a blood test to measure apixaban concentration.
Is the half-life of Eliquis the same in older adults?
Older adults may have slightly longer half-lives due to changes in kidney and liver function. Metabolism differences may also cause the medication to take longer to exit their body. This means the drug can stay in their system longer than in younger and more healthy patients.
Sources
Disclaimer: The information presented here is intended solely for educational purposes and should not be interpreted as medical advice, a diagnosis, or specific treatment recommendations. It does not imply endorsement of any particular medication or therapy. Health conditions and treatment responses can differ significantly between individuals; thus, this information is not a guarantee of safety, suitability, or effectiveness for anyone in particular. Always seek the guidance of a healthcare professional for personalized medical advice and consult them before making any health or treatment decisions.
